Metraipolis › archive › dc_2d4ae4a354fa
The Benefits and Risks of Glucagon-Like Peptide-1 Receptor Agonists on Ocular Diseases: A Narrative Review — Europe PMC PMID:41822624
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41822624
- DOI
- 10.7759/cureus.103234
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T01:03:43.869Z
- SHA-256 of the archived text
055832879feede661ac7a4dc00ccc917f1398ccfc2bf834be50c6efd5e5c8d41- Stable URL of this page
https://metraipolis.com/documento/dc_2d4ae4a354fa
How to cite
The Benefits and Risks of Glucagon-Like Peptide-1 Receptor Agonists on Ocular Diseases: A Narrative Review — Europe PMC PMID:41822624 — Europe PMC (en), https://europepmc.org/article/MED/41822624 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2d4ae4a354fa (Metraipolis archive dc_2d4ae4a354fa, sha256 055832879feede661ac7a4dc00ccc917f1398ccfc2bf834be50c6efd5e5c8d41)
BibTeX
@misc{dc2d4ae4a354fa,
title = {The Benefits and Risks of Glucagon-Like Peptide-1 Receptor Agonists on Ocular Diseases: A Narrative Review — Europe PMC PMID:41822624},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41822624},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2d4ae4a354fa; sha256 055832879feede661ac7a4dc00ccc917f1398ccfc2bf834be50c6efd5e5c8d41},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41822624. Agents can read the archived copy with the MCP tool read_document.